These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29222138)

  • 1. Application of Large-Scale Aptamer-Based Proteomic Profiling to Planned Myocardial Infarctions.
    Jacob J; Ngo D; Finkel N; Pitts R; Gleim S; Benson MD; Keyes MJ; Farrell LA; Morgan T; Jennings LL; Gerszten RE
    Circulation; 2018 Mar; 137(12):1270-1277. PubMed ID: 29222138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aptamer-Based Proteomic Profiling Reveals Novel Candidate Biomarkers and Pathways in Cardiovascular Disease.
    Ngo D; Sinha S; Shen D; Kuhn EW; Keyes MJ; Shi X; Benson MD; O'Sullivan JF; Keshishian H; Farrell LA; Fifer MA; Vasan RS; Sabatine MS; Larson MG; Carr SA; Wang TJ; Gerszten RE
    Circulation; 2016 Jul; 134(4):270-85. PubMed ID: 27444932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
    Smith JG; Gerszten RE
    Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiplexed, Quantitative Workflow for Sensitive Biomarker Discovery in Plasma Yields Novel Candidates for Early Myocardial Injury.
    Keshishian H; Burgess MW; Gillette MA; Mertins P; Clauser KR; Mani DR; Kuhn EW; Farrell LA; Gerszten RE; Carr SA
    Mol Cell Proteomics; 2015 Sep; 14(9):2375-93. PubMed ID: 25724909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Insights Into the Effects of Interleukin 6 Antagonism in Non-ST-Segment-Elevation Myocardial Infarction Employing the SOMAscan Proteomics Platform.
    George MJ; Kleveland O; Garcia-Hernandez J; Palmen J; Lovering R; Wiseth R; Aukrust P; Engmann J; Damås JK; Hingorani AD; Gullestad L; Casas JP; Ueland T
    J Am Heart Assoc; 2020 Jun; 9(12):e015628. PubMed ID: 32515246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aptamer-Based Proteomic Platform Identifies Novel Protein Predictors of Incident Heart Failure and Echocardiographic Traits.
    Nayor M; Short MI; Rasheed H; Lin H; Jonasson C; Yang Q; Hveem K; Felix JF; Morrison AC; Wild PS; Morley MP; Cappola TP; Benson MD; ; ; Ngo D; Sinha S; Keyes MJ; Shen D; Wang TJ; Larson MG; Brumpton BM; Gerszten RE; Omland T; Vasan RS
    Circ Heart Fail; 2020 May; 13(5):e006749. PubMed ID: 32408813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput targeted proteomics discovery approach and spontaneous reperfusion in ST-segment elevation myocardial infarction.
    Shavadia JS; Granger CB; Alemayehu W; Westerhout CM; Povsic TJ; Brener SJ; van Diepen S; Defilippi C; Armstrong PW
    Am Heart J; 2020 Feb; 220():137-144. PubMed ID: 31812755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic Discovery and Validation of the Confounding Effect of Heparin Administration on the Analysis of Candidate Cardiovascular Biomarkers.
    Beck HC; Jensen LO; Gils C; Ilondo AMM; Frydland M; Hassager C; Møller-Helgestad OK; Møller JE; Rasmussen LM
    Clin Chem; 2018 Oct; 64(10):1474-1484. PubMed ID: 30115630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aptamer-based multiplexed proteomic technology for biomarker discovery.
    Gold L; Ayers D; Bertino J; Bock C; Bock A; Brody EN; Carter J; Dalby AB; Eaton BE; Fitzwater T; Flather D; Forbes A; Foreman T; Fowler C; Gawande B; Goss M; Gunn M; Gupta S; Halladay D; Heil J; Heilig J; Hicke B; Husar G; Janjic N; Jarvis T; Jennings S; Katilius E; Keeney TR; Kim N; Koch TH; Kraemer S; Kroiss L; Le N; Levine D; Lindsey W; Lollo B; Mayfield W; Mehan M; Mehler R; Nelson SK; Nelson M; Nieuwlandt D; Nikrad M; Ochsner U; Ostroff RM; Otis M; Parker T; Pietrasiewicz S; Resnicow DI; Rohloff J; Sanders G; Sattin S; Schneider D; Singer B; Stanton M; Sterkel A; Stewart A; Stratford S; Vaught JD; Vrkljan M; Walker JJ; Watrobka M; Waugh S; Weiss A; Wilcox SK; Wolfson A; Wolk SK; Zhang C; Zichi D
    PLoS One; 2010 Dec; 5(12):e15004. PubMed ID: 21165148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Proteomics Profiling for Biomarker Discovery in Hypertrophic Cardiomyopathy.
    Shimada YJ; Hasegawa K; Kochav SM; Mohajer P; Jung J; Maurer MS; Reilly MP; Fifer MA
    J Cardiovasc Transl Res; 2019 Dec; 12(6):569-579. PubMed ID: 31278493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury.
    Lewis GD; Wei R; Liu E; Yang E; Shi X; Martinovic M; Farrell L; Asnani A; Cyrille M; Ramanathan A; Shaham O; Berriz G; Lowry PA; Palacios IF; Taşan M; Roth FP; Min J; Baumgartner C; Keshishian H; Addona T; Mootha VK; Rosenzweig A; Carr SA; Fifer MA; Sabatine MS; Gerszten RE
    J Clin Invest; 2008 Oct; 118(10):3503-12. PubMed ID: 18769631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new data mining approach for profiling and categorizing kinetic patterns of metabolic biomarkers after myocardial injury.
    Baumgartner C; Lewis GD; Netzer M; Pfeifer B; Gerszten RE
    Bioinformatics; 2010 Jul; 26(14):1745-51. PubMed ID: 20483816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High throughput and accurate serum proteome profiling by integrated sample preparation technology and single-run data independent mass spectrometry analysis.
    Lin L; Zheng J; Yu Q; Chen W; Xing J; Chen C; Tian R
    J Proteomics; 2018 Mar; 174():9-16. PubMed ID: 29278786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomic Profiling in Acute ST-Segment-Elevation Myocardial Infarction Identifies Succinate as an Early Marker of Human Ischemia-Reperfusion Injury.
    Kohlhauer M; Dawkins S; Costa ASH; Lee R; Young T; Pell VR; Choudhury RP; Banning AP; Kharbanda RK; ; Saeb-Parsy K; Murphy MP; Frezza C; Krieg T; Channon KM
    J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29626151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reference Values and Release Kinetics of B-Type Natriuretic Peptide Signal Peptide in Patients with Acute Myocardial Infarction.
    Liebetrau C; Gaede L; Dörr O; Blumenstein J; Rosenburg S; Hoffmann J; Troidl C; Hamm CW; Nef HM; Möllmann H; Richards AM; Pemberton CJ
    Clin Chem; 2015 Dec; 61(12):1532-9. PubMed ID: 26506995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a Multiplex Biomarker Panel for Hypertrophic Cardiomyopathy Using Quantitative Proteomics and Machine Learning.
    Captur G; Heywood WE; Coats C; Rosmini S; Patel V; Lopes LR; Collis R; Patel N; Syrris P; Bassett P; O'Brien B; Moon JC; Elliott PM; Mills K
    Mol Cell Proteomics; 2020 Jan; 19(1):114-127. PubMed ID: 31243064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
    Ho CY; Abbasi SA; Neilan TG; Shah RV; Chen Y; Heydari B; Cirino AL; Lakdawala NK; Orav EJ; González A; López B; Díez J; Jerosch-Herold M; Kwong RY
    Circ Cardiovasc Imaging; 2013 May; 6(3):415-22. PubMed ID: 23549607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-221 is a potential biomarker of myocardial hypertrophy and fibrosis in hypertrophic obstructive cardiomyopathy.
    Huang D; Chen Z; Wang J; Chen Y; Liu D; Lin K
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31868204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic Analysis of the Myocardium in Hypertrophic Obstructive Cardiomyopathy.
    Coats CJ; Heywood WE; Virasami A; Ashrafi N; Syrris P; Dos Remedios C; Treibel TA; Moon JC; Lopes LR; McGregor CGA; Ashworth M; Sebire NJ; McKenna WJ; Mills K; Elliott PM
    Circ Genom Precis Med; 2018 Dec; 11(12):e001974. PubMed ID: 30562113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic signatures predict preeclampsia in individual cohorts but not across cohorts - implications for clinical biomarker studies.
    Ghaemi MS; Tarca AL; Romero R; Stanley N; Fallahzadeh R; Tanada A; Culos A; Ando K; Han X; Blumenfeld YJ; Druzin ML; El-Sayed YY; Gibbs RS; Winn VD; Contrepois K; Ling XB; Wong RJ; Shaw GM; Stevenson DK; Gaudilliere B; Aghaeepour N; Angst MS
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):5621-5628. PubMed ID: 33653202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.